SCHEMBL6160744

SCHEMBL6160744

COc1ccc(Cc2ccc(OC)cc2N)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.50
ALDH1A1 P00352 5/20 0.49
CYP2D6 P10635 1/20 0.49
ATM Q13315 1/20 0.49
MEN1 O00255 2/20 0.48
MAPT P10636 2/20 0.48
THRB P10828 2/20 0.48
KMT2A Q03164 2/20 0.48
MPO P05164 1/20 0.48
KDM4E B2RXH2 1/20 0.47
GAA P10253 1/20 0.47
RECQL P46063 1/20 0.47
BLM P54132 1/20 0.47
MCL1 Q07820 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
LMNA P02545 1/20 0.46
HPGD P15428 1/20 0.46
IDO1 P14902 2/20 0.46
AGXT P21549 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6159073 0.90 MAOB (0.46) LTA4HALDH1A1CYP2D6ATMMEN1
SCHEMBL6159185 0.89 LTA4H (0.56) LTA4HALDH1A1MEN1MAPTTHRB
SCHEMBL21722570 0.88 ALDH1A1 (0.46) LTA4HALDH1A1CYP2D6ATMMAPT
SCHEMBL8218381 0.86 LTA4H (0.44) LTA4HALDH1A1CYP2D6ATMMPO
SCHEMBL225865 0.84 TAAR1 (0.53) ALDH1A1MEN1MAPTTHRBKMT2A
SCHEMBL6160843 0.81 LTA4H (0.60) LTA4HALDH1A1CYP2D6ATMMEN1
SCHEMBL4852727 0.80 ALDH1A1 (0.55) ALDH1A1MEN1MAPTTHRBKMT2A
SCHEMBL27606451 0.80 LTA4H (0.44) LTA4HALDH1A1CYP2D6ATMMPO
SCHEMBL5612174 0.79 APLNR (0.59) LTA4HALDH1A1MAPTGAA
SCHEMBL7846076 0.79 LTA4H (0.52) LTA4HIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0755923-B1 Ameliorant or remedy for symptoms caused by Ischemic diseases and Phenylpiperidine compounds useful therefor DAIICHI SUNTORY PHARMA CO LTD (JP) 2005-05-04 EP disclosed
US-6469010-B1 COMPOSITION ALSO FOR ALLEVIATION OR TREATMENT OF SYMPTOMS DERIVED FROM SEIZURES, EPILEPSY AND MIGRAINE HEADACHES, AND SUPPRESSION OF CALCIUM ION OVERLOAD SUNTORY LIMITED (JP) 2002-10-22 US disclosed
US-6048876-A ANTICONVULSANTS; ANTIEPILEPIC AGENT SUNTORY LIMITED (JP) 2000-04-11 US disclosed
EP-0755923-A1 AMELIORANT OR REMEDY FOR SYMPTOMS CAUSED BY ISCHEMIC DISEASES AND COMPOUNDS USEFUL THEREFOR SUNTORY LIMITED (JP) 1997-01-29 EP disclosed